Earnings Call · Q3 FY2023·2023-11-14

Q3 23EPS -0.59%·Rev n/aQ2 23EPS -5.47%·Rev n/aQ1 23EPS -20.83%·Rev n/aQ4 22EPS +20.75%·Rev n/a⚠ consensus missing

IMMUNIC, INC. IMUX

Jessica Breu — Head of Investor Relations and Communications

Dr. Daniel Vitt — Chief Executive Officer and President

Glenn Whaley — Chief Financial Officer

+2.2%1d on move date+0.2% vs SPY3d+6.3%5d+14.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IMUX calls or request research access.

More IMUX calls Browse calls Request research access